Gangliosidoses: primary disorders of ganglioside metabolism
Klibansky, C.
Harefuah 81(6): 289-293
1971
ISSN/ISBN: 0017-7768 PMID: 4946742 Document Number: 32627
Document emailed within 1 workday
Related Documents
Saito, T.; Irie, S. 1995: Anti-ganglioside antibodies in CIDP and related disorders Rinsho Shinkeigaku 35(12): 1376Zhang, D.; Ruan, Y.; Beyreuther, K. 1998: Effect of ganglioside GM1 on the metabolism of Alzheimer amyloid beta-protein precursor Zhonghua Yi Xue Za Zhi 78(3): 179-182
Kwiterovich, P.O. 2008: Primary and secondary disorders of lipid metabolism in pediatrics Pediatric Endocrinology Reviews: Per 5(Suppl 2): 727-738
Frank, O. 1974: Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia Wiener Klinische Wochenschrift 86(9): 252-256
Bremer, E.G.; Hakomori, S. 1982: GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: ganglioside may regulate growth factor receptor function Biochemical and Biophysical Research Communications 106(3): 711-718
Lin, Z.Y. 1990: Spectrum pattern and determination of ganglioside from human primary liver cancer of different origins Zhonghua Zhong Liu Za Zhi 12(5): 336-338
Debarbieux, S.éb.; Popa, I.; Thomas, L.; Kanitakis, J.; Pirot, F.; Portoukalian, J.; Haftek, M. 2009: Detection of GD3 ganglioside in primary melanomas depends on histopathologic procedures used for tumor preservation Acta Dermatovenerologica Croatica: Adc 17(3): 209-216
Abdul-Wahab, A.; Bessisso, M.S.; Elsaid, M.F. 2002: Sandhoff disease (GM2 Gangliosidoses) in a premature patient with bronchopulmonary dysplasia Saudi Medical Journal 23(5): 602-605
Majdecki, T. 1979: Ultrastructure of inclusion bodies in gangliosidoses and ceroidolipofuscinosis. Summary of doctoral dissertation Neuropatologia Polska 17(2): 323-331
Astakhova, L.N.; Asanova, N.K. 1985: Borderline neuropsychiatric disorders in purine metabolism disorders in children Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 85(3): 421-426
Rezaei, N.; Aghamohammadi, A.; Moin, M.; Pourpak, Z.; Movahedi, M.; Gharagozlou, M.; Atarod, L.; Ghazi, B.Mirsaeid.; Isaeian, A.; Mahmoudi, M.; Abolmaali, K.; Mansouri, D.; Arshi, S.; Tarash, N.Javaher.; Sherkat, R.; Akbari, H.; Amin, R.; Alborzi, A.; Kashef, S.; Farid, R.; Mohammadzadeh, I.; Shabestari, M.Sadeghi.; Nabavi, M.; Farhoudi, A. 2006: Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry Journal of Clinical Immunology 26(6): 519-532
del Vecchio, P. 1996: How should primary care address the problem of psychiatric disorders? Demand-side analysis of mental health services in primary care Behavioral Healthcare Tomorrow 5(5): 48 51 54
Fukumoto, S. 2010: Disorders of phosphate metabolism Rinsho Byori. Japanese Journal of Clinical Pathology 58(3): 225-231
Boyle, I. 1993: Disorders of calcium metabolism Practitioner 237(1526): 422-427
Murphy, E.; Bassett, J.H.D.; Williams, G.R. 2006: Disorders of calcium metabolism Practitioner 250(1686): 4-6; 8
Murphy, E.; Bassett, J.H.Duncan.; Williams, G.R. 2006: Disorders of calcium metabolism Practitioner 250(1686): 4-6 8
Miettinen, T. 1977: Cholesterol metabolism and its disorders Duodecim; Laaketieteellinen Aikakauskirja 93(10): 670-683
Kauf, E. 1980: Disorders of calcium metabolism Zeitschrift für Arztliche Fortbildung 74(13-14): 624-631
Madrenas Puig, J.; Pigrau Serrallach, C.; Martínez Vázquez, J.M. 1986: Magnesium metabolism and its disorders Medicina Clinica 87(4): 159-168
Segar, W.E.; Chesney, R.W. 1981: Disorders of electrolyte metabolism Pediatric Annals 10(8): 288-301